BIOMAT Database Logo BIOMAT Database Logo

Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study. 1987

E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Divisione de Gastroenterologia, Ospedale S. Martino, Genova.

A multicentre study involving 9 Italian institutions was carried out to compare the efficacy and safety of ranitidine 150 mg b.i.d. and ranitidine 300 mg nocte in the treatment of reflux oesophagitis. 117 patients with histologically proven oesophagitis were randomly allocated to two comparable treatment groups. Efficacy and reliability were evaluated by clinical and laboratory tests at the beginning of the study, and at 3 and 6 weeks; endoscopy and biopsies were performed at the beginning and at 6 weeks. Treatment with ranitidine for 6 weeks led to total disappearance of gastro-oesophageal reflux symptoms in 60% of patients, with percentages of partial improvement varying between 85% and 95% of cases. Improvement in the results of endoscopic examination was 85%, of which 55% were cured. Microscopic examination revealed an improvement of 36% and 44%, with a cure rate of 18% and 26% respectively. With regard neither to the regression of symptoms nor to the macroscopic and microscopic inflammation of the oesophageal mucosa did statistical examination show significant differences in the therapeutic efficacy of ranitidine 150 mg b.i.d. or 300 mg nocte for treatment of reflux oesophagitis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004942 Esophagitis, Peptic INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM. Esophagitis, Reflux,Esophagitides, Peptic,Esophagitides, Reflux,Peptic Esophagitides,Peptic Esophagitis,Reflux Esophagitides,Reflux Esophagitis
D004945 Esophagoscopy Endoscopic examination, therapy or surgery of the esophagus. Esophagoscopic Surgical Procedures,Surgical Procedures, Esophagoscopic,Esophagoscopic Surgery,Surgery, Esophagoscopic,Esophagoscopic Surgeries,Esophagoscopic Surgical Procedure,Esophagoscopies,Procedure, Esophagoscopic Surgical,Procedures, Esophagoscopic Surgical,Surgeries, Esophagoscopic,Surgical Procedure, Esophagoscopic
D005260 Female Females

Related Publications

E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.
June 1989, Alimentary pharmacology & therapeutics,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
April 1989, Alimentary pharmacology & therapeutics,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
A double-blind controlled trial of ranitidine 300 mg nocte and ranitidine 150 mg b.i.d. in the short-term treatment of gastric ulcer.
February 1986, International journal of clinical pharmacology, therapy, and toxicology,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
[3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
February 1990, Zeitschrift fur Gastroenterologie,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Comparison between ranitidine 150 mg b.d. and ranitidine 300 mg nocte in the treatment of duodenal ulcer.
July 1986, International journal of clinical pharmacology, therapy, and toxicology,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
February 2000, European journal of gastroenterology & hepatology,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo.
January 1992, The Italian journal of gastroenterology,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Treatment of reflux oesophagitis with ranitidine.
October 1983, Gut,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Comparison of ranitidine 300 mg nocte and 150 mg twice daily in the treatment of duodenal ulcer.
April 1988, The Journal of the Association of Physicians of India,
E Bovero, and R Cheli, and L Barbara, and F Baldi, and A Boero, and G C Mura, and E Camarri, and P Corradini, and G Dobrilla, and L Piazzi
Comparison of famotidine 40 mg with ranitidine 300 mg at night in short-term duodenal ulcer healing. A South African multicentre study.
July 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!